Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)

Forschungsprojekte

  1. NEOPA: Neoadjuvant Treatment in Resectable Pancreatic Cancer

    Izbicki, J. & Vettorazzi, E.

    01.07.1331.12.19

    Projekt: Forschung